Smith Group Asset Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-28,170
Closed -$186K 394
2020
Q1
$186K Hold
28,170
0.01% 170
2019
Q4
$292K Hold
28,170
0.01% 168
2019
Q3
$178K Buy
+28,170
New +$210K 0.01% 200

Other funds holding ARA

Smith Group Asset Management's ARA Position: Q2 2020 in Review

Smith Group Asset Management sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2020, closing a stake of 28,170 shares — an estimated $186K sold.

Smith Group Asset Management first reported a position in ARA in Q3 2019 and held it in 3 quarters. The position peaked at $292K in Q4 2019. 56 funds tracked by Wall St. Rank hold ARA as of Q2 2020.

  • Smith Group Asset Management reported no remaining American Renal Associates Holdings, Inc position as of Q2 2020 after selling out during the quarter.
  • Smith Group Asset Management sold 28,170 American Renal Associates Holdings, Inc shares in Q2 2020, an estimated $186K.
  • Smith Group Asset Management first reported a position in American Renal Associates Holdings, Inc in Q3 2019 and held it in 3 quarters.
  • Smith Group Asset Management's American Renal Associates Holdings, Inc position peaked at $292K in Q4 2019.
  • 56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2020.

Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.